2cf9
From Proteopedia
Line 1: | Line 1: | ||
- | [[Image:2cf9.gif|left|200px]]<br /> | + | [[Image:2cf9.gif|left|200px]]<br /><applet load="2cf9" size="450" color="white" frame="true" align="right" spinBox="true" |
- | <applet load="2cf9" size="450" color="white" frame="true" align="right" spinBox="true" | + | |
caption="2cf9, resolution 1.79Å" /> | caption="2cf9, resolution 1.79Å" /> | ||
'''THROMBIN-METHOXY2'''<br /> | '''THROMBIN-METHOXY2'''<br /> | ||
Line 11: | Line 10: | ||
==About this Structure== | ==About this Structure== | ||
- | 2CF9 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with NA, CA, SIN and 348 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Thrombin Thrombin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.5 3.4.21.5] | + | 2CF9 is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with NA, CA, SIN and 348 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Thrombin Thrombin], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=3.4.21.5 3.4.21.5] Known structural/functional Site: <scene name='pdbsite=AC1:Ca Binding Site For Chain H'>AC1</scene>. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2CF9 OCA]. |
==Reference== | ==Reference== | ||
Line 39: | Line 38: | ||
[[Category: serine protease inhibitor complex]] | [[Category: serine protease inhibitor complex]] | ||
- | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Tue Dec 18 19:20:07 2007'' |
Revision as of 17:10, 18 December 2007
|
THROMBIN-METHOXY2
Contents |
Overview
Two series of tricyclic inhibitors of the serine protease thrombin, imides, (+/-)-1-(+/-)-8 and lactams (+/-)-9-(+/-)-13, were analysed to evaluate, contributions of orthogonal multipolar interactions with the backbone C=O, moiety of Asn98 to the free enthalpy of protein-ligand complexation. The, lactam derivatives are much more potent and more selective inhibitors, (K(i) values between 0.065 and 0.005 microM, selectivity for thrombin over, trypsin between 361- and 1609-fold) than the imide compounds (Ki values, between 0.057 and 23.7 microM, selectivity for thrombin over trypsin, between 3- and 67-fold). The increase in potency and selectivity is, explained by the favorable occupancy of the P-pocket of thrombin by the, additional isopropyl substituent in the lactam derivatives. The nature of, the substituent on the benzyl ring filling the D pocket strongly, influences binding potency in the imide series, with Ki values increasing, in the sequence: F < OCH2O < Cl < H < OMe < OH < N(pyr)<< Br. This, sequence can be explained by both steric fit and the occurrence of, orthogonal multipolar interactions with the backbone C[double bond, length, as m-dash]O moiety of Asn98. In contrast, the substituent on the benzyl, ring hardly affects the ligand potency in the lactam series. This, discrepancy was clarified by the comparison of X-ray structures solved for, co-crystals of thrombin with imide and lactam ligands. Whereas the benzyl, substituents in the imide inhibitors are sufficiently close (< or =3.5, Angstroms) to the C=O group of Asn98 to allow for attractive orthogonal, multipolar interactions, the distances in the lactam series are too large, (> or =4 Angstroms) for attractive dipolar contacts to be effective.
Disease
Known diseases associated with this structure: Dysprothrombinemia OMIM:[176930], Hyperprothrombinemia OMIM:[176930], Hypoprothrombinemia OMIM:[176930]
About this Structure
2CF9 is a Protein complex structure of sequences from Homo sapiens with NA, CA, SIN and 348 as ligands. Active as Thrombin, with EC number 3.4.21.5 Known structural/functional Site: . Full crystallographic information is available from OCA.
Reference
Multipolar interactions in the D pocket of thrombin: large differences between tricyclic imide and lactam inhibitors., Schweizer E, Hoffmann-Roder A, Olsen JA, Seiler P, Obst-Sander U, Wagner B, Kansy M, Banner DW, Diederich F, Org Biomol Chem. 2006 Jun 21;4(12):2364-75. Epub 2006 May 10. PMID:16763681
Page seeded by OCA on Tue Dec 18 19:20:07 2007
Categories: Homo sapiens | Protein complex | Thrombin | Banner, D.W. | Diederich, F. | Hoffmann-Roeder, A. | Kansy, M. | Obst-Sander, U. | Olsen, J.A. | Schweizer, E. | Wagner, B. | 348 | CA | NA | SIN | Acute phase | Blood coagulation | Calcium-binding | Complex hydrolase/inhibitor | Glycoprotein | Hydolase | Serine protease | Serine protease inhibitor complex